tradingkey.logo
搜尋

Repligen Corp

RGEN
添加自選
107.030USD
-6.570-5.78%
收盤 05/13, 16:00美東報價延遲15分鐘
6.41B總市值
117.17本益比TTM

Repligen Corp

107.030
-6.570-5.78%

關於 Repligen Corp 公司

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.

Repligen Corp簡介

公司代碼RGEN
公司名稱Repligen Corp
上市日期Apr 29, 1986
CEOLoeillot (Olivier)
員工數量1778
證券類型Ordinary Share
年結日Apr 29
公司地址Building 1, Suite 100
城市WALTHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編02453
電話17814499560
網址https://www.repligen.com/
公司代碼RGEN
上市日期Apr 29, 1986
CEOLoeillot (Olivier)

Repligen Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Ms. Karen A. Dawes
Ms. Karen A. Dawes
Lead Independent Director
Lead Independent Director
91.82K
+0.87%
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
39.06K
+6.23%
Mr. Ralf Kuriyel
Mr. Ralf Kuriyel
Senior Vice President - Research and Development
Senior Vice President - Research and Development
9.42K
-28.60%
Mr. Nicolas M. Barthelemy
Mr. Nicolas M. Barthelemy
Independent Director
Independent Director
4.44K
-11.24%
Mr. Rohin Mhatre, Ph.D.
Mr. Rohin Mhatre, Ph.D.
Independent Director
Independent Director
4.02K
+17.44%
Mr. Olivier Loeillot
Mr. Olivier Loeillot
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.22K
-155.54%
Mr. Tony John Hunt
Mr. Tony John Hunt
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Ms. Carrie Eglinton Manner
Ms. Carrie Eglinton Manner
Independent Director
Independent Director
--
--
Mr. James R. Bylund
Mr. James R. Bylund
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Konstantin Konstantinov, Ph.D.
Dr. Konstantin Konstantinov, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Karen A. Dawes
Ms. Karen A. Dawes
Lead Independent Director
Lead Independent Director
91.82K
+0.87%
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
39.06K
+6.23%
Mr. Ralf Kuriyel
Mr. Ralf Kuriyel
Senior Vice President - Research and Development
Senior Vice President - Research and Development
9.42K
-28.60%
Mr. Nicolas M. Barthelemy
Mr. Nicolas M. Barthelemy
Independent Director
Independent Director
4.44K
-11.24%
Mr. Rohin Mhatre, Ph.D.
Mr. Rohin Mhatre, Ph.D.
Independent Director
Independent Director
4.02K
+17.44%
Mr. Olivier Loeillot
Mr. Olivier Loeillot
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.22K
-155.54%

收入明細

單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Product revenue - Filtration products
402.79M
54.58%
Product revenue-Chromatography products
153.18M
20.76%
Product revenu - Protein products
97.44M
13.20%
Product revenue-Process analytics products
81.24M
11.01%
Other
3.32M
0.45%
地區USD
名稱
營收
佔比
North America
361.60M
49.00%
Europe
250.91M
34.00%
APAC/Other
125.45M
17.00%
業務
地區
業務USD
名稱
營收
佔比
Product revenue - Filtration products
402.79M
54.58%
Product revenue-Chromatography products
153.18M
20.76%
Product revenu - Protein products
97.44M
13.20%
Product revenue-Process analytics products
81.24M
11.01%
Other
3.32M
0.45%

股東統計

更新時間: 46 分鐘前
更新時間: 46 分鐘前
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
8.31%
T. Rowe Price Associates, Inc.
8.06%
United Capital Financial Advisors, LLC
4.91%
Roy T. Eddleman UEO
4.85%
Vanguard Capital Management, LLC
4.25%
其他
69.62%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
8.31%
T. Rowe Price Associates, Inc.
8.06%
United Capital Financial Advisors, LLC
4.91%
Roy T. Eddleman UEO
4.85%
Vanguard Capital Management, LLC
4.25%
其他
69.62%
股東類型
持股股東
佔比
Investment Advisor
62.92%
Investment Advisor/Hedge Fund
38.33%
Hedge Fund
9.18%
Individual Investor
5.23%
Research Firm
1.98%
Pension Fund
1.75%
Bank and Trust
0.82%
Sovereign Wealth Fund
0.82%
Private Equity
0.56%

機構持股

更新時間: 4月5日 週日
更新時間: 4月5日 週日
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
1067
65.93M
116.89%
-2.64M
2025Q4
1044
63.74M
113.23%
+2.55M
2025Q3
1027
55.23M
98.12%
-6.26M
2025Q2
1028
61.98M
110.32%
-3.21M
2025Q1
1054
62.91M
111.98%
-2.72M
2024Q4
1054
61.13M
109.11%
-3.76M
2024Q3
1046
60.75M
108.48%
-6.10M
2024Q2
1039
61.28M
109.67%
-2.73M
2024Q1
1036
60.56M
108.45%
-5.41M
2023Q4
1062
62.13M
111.29%
-2.30M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
4.69M
8.32%
+51.74K
+1.12%
Dec 31, 2025
T. Rowe Price Associates, Inc.
4.55M
8.07%
+1.09M
+31.55%
Dec 31, 2025
United Capital Financial Advisors, LLC
2.77M
4.92%
+14.92K
+0.54%
Dec 31, 2025
Roy T. Eddleman UEO
2.74M
4.86%
-576.21K
-17.40%
Dec 31, 2025
Fidelity Management & Research Company LLC
2.36M
4.19%
+67.67K
+2.95%
Dec 31, 2025
State Street Investment Management (US)
1.72M
3.05%
-82.44K
-4.58%
Dec 31, 2025
Citadel Advisors LLC
1.39M
2.48%
-290.47K
-17.24%
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
First Trust NYSE Arca Biotechnology Index Fund
3.45%
Alger Mid Cap 40 ETF
3.1%
Congress SMid Growth ETF
2.46%
iShares Health Innovation Active ETF
2.28%
VanEck Biotech ETF
1.34%
Franklin Genomic Advancements ETF
1.23%
Pacer US Export Leaders ETF
1.18%
Alger 35 ETF
1.15%
WisdomTree BioRevolution Fund
1.06%
iShares Biotechnology ETF
0.7%
查看更多
First Trust NYSE Arca Biotechnology Index Fund
佔比3.45%
Alger Mid Cap 40 ETF
佔比3.1%
Congress SMid Growth ETF
佔比2.46%
iShares Health Innovation Active ETF
佔比2.28%
VanEck Biotech ETF
佔比1.34%
Franklin Genomic Advancements ETF
佔比1.23%
Pacer US Export Leaders ETF
佔比1.18%
Alger 35 ETF
佔比1.15%
WisdomTree BioRevolution Fund
佔比1.06%
iShares Biotechnology ETF
佔比0.7%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI